Concentration of homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid after treatment with probenecid in patients with drug-induced tardive dyskinesia.
D004298:Dopamine / Q000502:physiology; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid*; D009069:Movement Disorders / Q000139:chemically induced / Q000188:drug therapy*; D010648:Phenylacetates / Q000134:cerebrospinal fluid*; D011339:Probenecid / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy; D012701:Serotonin / Q000502:physiology; D009435:Synaptic Transmission; D014149:Tranquilizing Agents / Q000009:adverse effects
D010648:Phenylacetates; D014149:Tranquilizing Agents; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D011339:Probenecid; D004298:Dopamine